Erythrocyte-derived liposomes for the treatment of inflammatory diseases.

Bibliographic reference: 

Olival A, Vieira SF, Gonçalves VMF, Cunha C, Tiritan ME, Carvalho A, Reis RL, Ferreira H, Neves NM. Erythrocyte-derived liposomes for the treatment of inflammatory diseases. J Drug Target. 2022 Sep;30(8):873-883. doi: 10.1080/1061186X.2022.2066107.